Variant report

Variant	nsv873774
Chromosome Location	chr2:31363732-31432367
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr2:31416013-31416428	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL3	chr2:31423822-31424213	GM12878	blood:	n/a	n/a
3	BHLHE40	chr2:31373267-31373299	GM12878	blood:	n/a	n/a
4	BHLHE40	chr2:31392783-31393324	GM12878	blood:	n/a	n/a
5	BHLHE40	chr2:31430809-31431053	GM12878	blood:	n/a	n/a
6	BRCA1	chr2:31393063-31393227	HepG2	liver:	n/a	n/a
7	CEBPB	chr2:31427020-31427332	HepG2	liver:	n/a	chr2:31427167-31427178
8	CEBPB	chr2:31367564-31367651	A549	lung:	n/a	n/a
9	CEBPB	chr2:31427031-31427326	IMR90	lung:	n/a	chr2:31427167-31427178
10	CEBPB	chr2:31427049-31427251	K562	blood:	n/a	chr2:31427167-31427178
11	CEBPB	chr2:31426991-31427339	A549	lung:	n/a	chr2:31427167-31427178
12	CEBPB	chr2:31386150-31386350	HepG2	liver:	n/a	n/a
13	CEBPB	chr2:31426142-31426190	K562	blood:	n/a	n/a
14	CHD1	chr2:31392749-31393414	IMR90	lung:	n/a	n/a
15	CHD2	chr2:31415980-31416180	H1-hESC	embryonic stem cell:	n/a	n/a
16	CTCF	chr2:31393080-31393230	HVMF	connective:	n/a	chr2:31393139-31393155
17	CTCF	chr2:31393060-31393210	GM12869	blood:	n/a	chr2:31393139-31393155
18	CTCF	chr2:31392923-31393315	T-47D	breast:	n/a	chr2:31393139-31393155
19	CTCF	chr2:31393857-31393925	Fibrobl	skin:	n/a	n/a
20	CTCF	chr2:31374505-31374649	Gliobla	brain:	n/a	chr2:31374566-31374587 chr2:31374573-31374591 chr2:31374575-31374596 chr2:31374571-31374589
21	CTCF	chr2:31393040-31393190	GM12869	blood:	n/a	chr2:31393139-31393155
22	CTCF	chr2:31374520-31374670	AG09319	gingival:	n/a	chr2:31374566-31374587 chr2:31374573-31374591 chr2:31374575-31374596 chr2:31374571-31374589
23	CTCF	chr2:31374536-31374628	NHEK	skin:	n/a	chr2:31374566-31374587 chr2:31374573-31374591 chr2:31374575-31374596 chr2:31374571-31374589
24	CTCF	chr2:31374540-31374690	Caco-2	colon:	n/a	chr2:31374566-31374587 chr2:31374573-31374591 chr2:31374575-31374596 chr2:31374571-31374589
25	CTCF	chr2:31393080-31393230	HPF	lung:	n/a	chr2:31393139-31393155
26	CTCF	chr2:31374540-31374690	HRE	kidney:	n/a	chr2:31374566-31374587 chr2:31374573-31374591 chr2:31374575-31374596 chr2:31374571-31374589
27	CTCF	chr2:31393100-31393250	HMF	breast:	n/a	chr2:31393139-31393155
28	CTCF	chr2:31393080-31393230	HMEC	breast:	n/a	chr2:31393139-31393155
29	CTCF	chr2:31393460-31393610	GM12865	blood:	n/a	n/a
30	CTCF	chr2:31374520-31374670	HMEC	breast:	n/a	chr2:31374566-31374587 chr2:31374573-31374591 chr2:31374575-31374596 chr2:31374571-31374589
31	CTCF	chr2:31416000-31416150	GM12873	blood:	n/a	n/a
32	CTCF	chr2:31393480-31393630	HA-sp	spinal cord:	n/a	n/a
33	CTCF	chr2:31374440-31374590	WERI-Rb-1	eye:	n/a	chr2:31374566-31374587 chr2:31374571-31374589
34	CTCF	chr2:31393060-31393210	AG04450	lung:	n/a	chr2:31393139-31393155
35	CTCF	chr2:31393080-31393230	HRPEpiC	eye:	n/a	chr2:31393139-31393155
36	CTCF	chr2:31393349-31393352	LNCaP	prostate:	n/a	n/a
37	CTCF	chr2:31374480-31374630	AG10803	skin:	n/a	chr2:31374566-31374587 chr2:31374573-31374591 chr2:31374575-31374596 chr2:31374571-31374589
38	CTCF	chr2:31393080-31393230	AG09309	skin:	n/a	chr2:31393139-31393155
39	CTCF	chr2:31392987-31393297	GM19240	blood:	n/a	chr2:31393139-31393155
40	CTCF	chr2:31374540-31374690	BJ	skin:	n/a	chr2:31374566-31374587 chr2:31374573-31374591 chr2:31374575-31374596 chr2:31374571-31374589
41	CTCF	chr2:31393080-31393230	Hela-S3	cervix:	n/a	chr2:31393139-31393155
42	CTCF	chr2:31415956-31416297	H1-hESC	embryonic stem cell:	n/a	n/a
43	CTCF	chr2:31393100-31393250	A549	lung:	n/a	chr2:31393139-31393155
44	CTCF	chr2:31392999-31393301	GM19239	blood:	n/a	chr2:31393139-31393155
45	CTCF	chr2:31393080-31393230	GM12866	blood:	n/a	chr2:31393139-31393155
46	CTCF	chr2:31393100-31393250	GM12871	blood:	n/a	chr2:31393139-31393155
47	CTCF	chr2:31374553-31374603	ProgFib	skin:	n/a	chr2:31374566-31374587 chr2:31374573-31374591 chr2:31374575-31374596 chr2:31374571-31374589
48	CTCF	chr2:31364800-31364950	GM12875	blood:	n/a	n/a
49	CTCF	chr2:31424022-31424079	GM12892	blood:	n/a	n/a
50	CTCF	chr2:31416063-31416278	K562	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:31378368-31378418	NT2-D1	testis:	n/a
2	chr2:31397283-31397333	HAEpiC	amniotic membrane:	n/a
3	chr2:31378368-31378418	NT2-D1	testis:	n/a
4	chr2:31397283-31397333	HAEpiC	amniotic membrane:	n/a
5	chr2:31397283-31397333	H1-hESC	embryonic stem cell:	embryo
6	chr2:31364468-31364518	SK-N-MC	brain:	n/a
7	chr2:31400310-31400360	Hepatocyte	liver:	n/a
8	chr2:31378999-31379049	HCF	heart:	n/a
9	chr2:31378999-31379049	HRE	kidney:	n/a
10	chr2:31364468-31364518	HCM	heart:	n/a
11	chr2:31378368-31378418	HepG2	liver:	n/a
12	chr2:31378368-31378418	SK-N-SH_RA	brain:	n/a
13	chr2:31400310-31400360	SK-N-SH_RA	brain:	n/a
14	chr2:31397283-31397333	AG04449	skin:	fetal
15	chr2:31378368-31378418	HIPEpiC	eye:	n/a
16	chr2:31397283-31397333	HCPEpiC	choroid plexus:	n/a
17	chr2:31378999-31379049	GM12891	blood:	n/a
18	chr2:31378368-31378418	NH-A	brain:	n/a
19	chr2:31364468-31364518	NT2-D1	testis:	n/a
20	chr2:31397283-31397333	T-47D	breast:	n/a
21	chr2:31364468-31364518	BE2_C	brain:	n/a
22	chr2:31397283-31397333	K562	blood:	n/a
23	chr2:31400310-31400360	HIPEpiC	eye:	n/a
24	chr2:31364468-31364518	HAEpiC	amniotic membrane:	n/a
25	chr2:31400310-31400360	HRPEpiC	eye:	n/a
26	chr2:31397283-31397333	ProgFib	skin:	n/a
27	chr2:31400310-31400360	GM06990	blood:	n/a
28	chr2:31378368-31378418	GM19239	blood:	n/a
29	chr2:31397283-31397333	GM12891	blood:	n/a
30	chr2:31378999-31379049	MCF10A-Er-Src	breast:	n/a
31	chr2:31378368-31378418	ECC-1	luminal epithelium:	n/a
32	chr2:31400310-31400360	HUVEC	blood vessel:	n/a
33	chr2:31400310-31400360	PFSK-1	brain:	n/a
34	chr2:31400310-31400360	AG04450	lung:	fetal
35	chr2:31364468-31364518	MCF10A-Er-Src	breast:	n/a
36	chr2:31378368-31378418	MCF-7	breast:	n/a
37	chr2:31397283-31397333	MCF10A-Er-Src	breast:	n/a
38	chr2:31378999-31379049	HCPEpiC	choroid plexus:	n/a
39	chr2:31378368-31378418	HEEpiC	esophagus:	n/a
40	chr2:31364468-31364518	HEEpiC	esophagus:	n/a
41	chr2:31364468-31364518	HepG2	liver:	n/a
42	chr2:31378999-31379049	GM12892	blood:	n/a
43	chr2:31400310-31400360	CMK	blood:	n/a
44	chr2:31378999-31379049	PANC-1	pancreas:	n/a
45	chr2:31378999-31379049	LNCaP	prostate:	n/a
46	chr2:31364468-31364518	ProgFib	skin:	n/a
47	chr2:31378999-31379049	GM19239	blood:	n/a
48	chr2:31378368-31378418	K562	blood:	n/a
49	chr2:31378368-31378418	HAEpiC	amniotic membrane:	n/a
50	chr2:31400310-31400360	SAEC	small airway:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:31408453..31411420-chr2:31417636..31420052,2	MCF-7	breast:
2	chr2:31368930..31370626-chr2:31374002..31376231,2	K562	blood:
3	chr2:31410117..31413014-chr2:31413496..31415542,2	MCF-7	breast:
4	chr2:31382368..31384953-chr2:31385943..31389516,3	K562	blood:
5	chr2:31418550..31420224-chr2:31425779..31428465,2	K562	blood:
6	chr2:31407024..31409183-chr2:31430215..31431751,2	MCF-7	breast:
7	chr2:30937140..30937644-chr2:31393091..31393610,2	MCF-7	breast:
8	chr2:31408453..31411420-chr2:31417636..31420052,2	MCF-7	breast:
9	chr2:31372563..31374637-chr2:31556201..31557717,2	MCF-7	breast:
10	chr2:31374189..31375034-chr2:31392805..31393608,2	MCF-7	breast:
11	chr2:31084008..31085526-chr2:31392671..31393659,6	MCF-7	breast:
12	chr2:31407024..31409183-chr2:31430215..31431751,2	MCF-7	breast:
13	chr2:31085085..31085843-chr2:31392722..31393572,3	K562	blood:
14	chr2:31418550..31420224-chr2:31425779..31428465,2	K562	blood:
15	chr2:31354945..31357543-chr2:31362533..31364152,2	MCF-7	breast:
16	chr2:30934393..30935214-chr2:31392750..31393384,3	MCF-7	breast:
17	chr2:31410117..31413014-chr2:31413496..31415542,2	MCF-7	breast:
18	chr2:31382368..31384953-chr2:31385943..31389516,3	K562	blood:
19	chr2:31272032..31272775-chr2:31392833..31393525,2	MCF-7	breast:
20	chr2:31361200..31361839-chr2:31415622..31416505,2	MCF-7	breast:
21	chr2:31374189..31375034-chr2:31392805..31393608,2	MCF-7	breast:
22	chr2:31374076..31374959-chr2:31556105..31557134,5	MCF-7	breast:
23	chr2:30934379..30935101-chr2:31392582..31393517,4	MCF-7	breast:
24	chr2:30938969..30939544-chr2:31392686..31393613,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CAPN14-2	chr2:31369788-31371824	NONHSAT069931
2	lnc-CAPN14-2	chr2:31369788-31369844	NONHSAT069929
3	lnc-CAPN14-2	chr2:31366725-31366942	NONHSAT069931

Variant related genes	Relation type
GALNT14	TF binding region
GALNT14	CpG island
ENSG00000158089	chromatin interactions

Extended variants
information (count: 2913 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:2913 , 50 per page) page: 1 2 3 4 5 6 7 ... 59

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1530394	chr2:31363732-31363733	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs534966530	chr2:31363745-31363746	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs374843297	chr2:31363793-31363794	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs199892002	chr2:31363794-31363795	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs111600726	chr2:31363797-31363798	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs13408448	chr2:31363800-31363801	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs181526481	chr2:31363803-31363804	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs186189166	chr2:31363844-31363845	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs60112587	chr2:31363856-31363857	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs189292809	chr2:31363874-31363875	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs528471798	chr2:31363899-31363900	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs542166507	chr2:31363921-31363922	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs562371725	chr2:31363939-31363940	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs116156040	chr2:31363940-31363941	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs551212299	chr2:31363988-31363989	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs538140209	chr2:31363989-31363990	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs556622322	chr2:31363998-31363999	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs578109012	chr2:31364031-31364032	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs535993131	chr2:31364085-31364086	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs571043145	chr2:31364089-31364090	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs532264105	chr2:31364103-31364104	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs201410890	chr2:31364123-31364124	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs201795390	chr2:31364124-31364125	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs551985428	chr2:31364138-31364139	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs565711925	chr2:31364176-31364177	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs534329922	chr2:31364188-31364189	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs370379306	chr2:31364200-31364201	Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs372002069	chr2:31364206-31364207	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs554094187	chr2:31364245-31364246	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs148675304	chr2:31364255-31364256	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs116602342	chr2:31364272-31364273	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs556770473	chr2:31364330-31364331	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs181952028	chr2:31364335-31364336	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs546324567	chr2:31364338-31364339	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs186564752	chr2:31364347-31364348	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs573242456	chr2:31364407-31364408	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs541881045	chr2:31364468-31364469	Enhancers Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs114051044	chr2:31364494-31364495	Enhancers Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs11893586	chr2:31364501-31364502	Enhancers Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs189840262	chr2:31364535-31364536	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs528013152	chr2:31364538-31364539	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs182964372	chr2:31364588-31364589	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs367684407	chr2:31364592-31364593	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs186212016	chr2:31364595-31364596	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs374755771	chr2:31364618-31364619	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs191503478	chr2:31364722-31364723	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs115099135	chr2:31364746-31364747	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs567701148	chr2:31364755-31364756	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs536976124	chr2:31364756-31364757	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs556833644	chr2:31364780-31364781	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Autism	22495311	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Medulloblastoma	16968546	CNVD
Leukemia	18628472	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Breast cancer	21364760	CNVD
Wilms tumour	21544195	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	18927303	CNVD
Hepatocellular carcinoma	16750200	CNVD
Lung cancer	16740712	CNVD
Hereditary gingival fibromatosis	19633868	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21509527	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:186 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:31360800-31365400	Enhancers	Fetal Brain Male	brain
2	chr2:31361800-31365200	Enhancers	Fetal Brain Female	brain
3	chr2:31361800-31369400	Weak transcription	Right Atrium	heart
4	chr2:31362000-31364200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr2:31362200-31364400	Weak transcription	Brain Germinal Matrix	brain
6	chr2:31363800-31364000	Enhancers	Fetal Thymus	thymus
7	chr2:31364200-31364400	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
8	chr2:31364200-31364600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
9	chr2:31364200-31365000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr2:31364200-31365200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr2:31364400-31365000	Enhancers	Brain Germinal Matrix	brain
12	chr2:31364600-31364800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr2:31364600-31365000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr2:31364800-31365000	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
15	chr2:31364800-31365000	Enhancers	Fetal Thymus	thymus
16	chr2:31365000-31370600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr2:31365200-31366600	Weak transcription	Fetal Brain Female	brain
18	chr2:31365400-31365600	Enhancers	ES-I3 Cell Line	embryonic stem cell
19	chr2:31365600-31365800	Enhancers	iPS-18 Cell Line	embryonic stem cell
20	chr2:31366600-31367000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
21	chr2:31366800-31367000	Enhancers	H1 Cell Line	embryonic stem cell
22	chr2:31366800-31367000	Enhancers	Fetal Brain Female	brain
23	chr2:31366800-31367200	Enhancers	H9 Cell Line	embryonic stem cell
24	chr2:31366800-31367200	Enhancers	HUES64 Cell Line	embryonic stem cell
25	chr2:31366800-31367200	Enhancers	iPS-18 Cell Line	embryonic stem cell
26	chr2:31368000-31368400	Enhancers	Pancreatic Islets	Pancreatic Islet
27	chr2:31368400-31370800	Weak transcription	Pancreatic Islets	Pancreatic Islet
28	chr2:31370600-31370800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr2:31370800-31371200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr2:31371000-31371400	Enhancers	HSMM	muscle
31	chr2:31371600-31371800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr2:31377800-31379000	Enhancers	A549	lung
33	chr2:31378400-31378800	Enhancers	Fetal Brain Male	brain
34	chr2:31378400-31380800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
35	chr2:31378600-31378800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr2:31378800-31383200	Weak transcription	Fetal Brain Male	brain
37	chr2:31379000-31379200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr2:31380800-31381400	Enhancers	Primary B cells from peripheral blood	blood
39	chr2:31381000-31381200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
40	chr2:31381200-31381600	Enhancers	Brain Germinal Matrix	brain
41	chr2:31381600-31382600	Weak transcription	Brain Germinal Matrix	brain
42	chr2:31382600-31384000	Enhancers	Brain Germinal Matrix	brain
43	chr2:31383200-31383600	Enhancers	Fetal Brain Male	brain
44	chr2:31383600-31383800	Weak transcription	Fetal Brain Male	brain
45	chr2:31383800-31385200	Enhancers	Fetal Brain Male	brain
46	chr2:31384000-31385000	Flanking Active TSS	Brain Germinal Matrix	brain
47	chr2:31384600-31385000	Enhancers	Primary B cells from peripheral blood	blood
48	chr2:31384800-31385000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
49	chr2:31385000-31387200	Enhancers	Brain Germinal Matrix	brain
50	chr2:31385000-31387800	Weak transcription	Primary B cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links